Analysts welcome Aurobindo calling off stake buy in Cronus

Aurobindo shares have fallen 36% from their 52-week high of Rs 1,063.75 hit on May 11. The companys lower-than-expected June quarter results, seven observations by the US drug regulator after the inspection of its Unit 1 plant and the Cronus acquisition for $56 million have accentuated the stocks slide in recent weeks.

via Economictimes